May 24, 2013     Japanese 
  JCN Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Company
News Sectors
Automotive
Communications
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Research
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
News Alerts
News Search
Photo Gallery
Company Login
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
 
 
SDK Develops Organic EL Devices with Light Output of 40%
SDK Develops Organic EL Devices with Light Output of 40%
Tokyo, July 28, 2009 - (JCN Newswire) - Showa Denko K.K. (SDK) has developed a new structure for its organic electroluminescent (organic EL) devices, achieving approximately 40% in light output, which represents the highest level in the world. As a result, SDK has achieved a 30 lm/W emissive efficiency for its coated phosphorescent-polymer-based organic EL devices. ("Emissive efficiency" refers to the quantity of light emitted from light source, divided by electric power consumed.) The 30 lm/W emissive efficiency represents the highest level among coated-type organic EL devices that have been announced in the world.   [ more... ]

 Headline News

Suzuki Foundation Awards Latest Scientific Research Funding (Feb 15, 2013)
The Suzuki Foundation has selected 29 scientific research initiatives to receive fiscal 2012 financial assistance worth a total of 39.95 million yen. The foundation also announced financial support for academic research, bringing its overall fiscal 2012 disbursements to 48.68 million yen. more info >>
 | News Archives...   
ACN Newswire
 Press Release News

Cima NanoTech Unveils Next Generation SANTE(TM) Films to Drive Greater Adoption of Touch Screens for Large-format, Multi-touch Displays (May 17, 2013)
Cima NanoTech Unveils Next Generation SANTE(TM) Films to Drive Greater Adoption of Touch Screens for Large-format, Multi-touch Displays more info >>
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing (May 17, 2013)
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology. more info >>
Optimizing Nanoparticles for Commercial Applications (Apr 26, 2013)
Nanoparticles are currently used in commercial products ranging from catalysts, polishing media and magnetic fluids to cosmetics and sunscreens. more info >>
A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases (Apr 25, 2013)
A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases more info >>
Understanding Abnormal Proteins in Degenerative Diseases (Apr 22, 2013)
Understanding Abnormal Proteins in Degenerative Diseases more info >>
 |  More Press Release...
JCN Network - Company Profiles - Company Listing
 
CSR Report Download
Most Popular
Copyright © 2013 JCN Newswire - Japan Corporate News Network (JCN) K.K.
About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)